NASDAQ: REGN       Regeneron Pharmaceutical
Last Price Today's Change   Day's Range   Trading Volume
331.80   -7.28 (2.15%)  330.691 - 352.59  358,205


Avg Volume (4 weeks):804,989
4 Weeks Range:315.15 - 352.59
4 Weeks Price Volatility (%):
52 Weeks Range:313.53 - 543.552
52 Weeks Price Volatility (%):
Average Price Target: 430.00
Price Target Upside/Downside: +98.20


No recent Headlines for this stock.

Business Background

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.

  Be the first to like this.


2964  4504  476  612 

Top 10 Active Counters
 FB 162.80-9.76 
 GE 13.675-0.395 
 NVCN 0.111-0.013 
 TWTR 30.67-4.31 
 ORCL 47.075-4.875 
 AMD 11.14-0.29 
 ENRJ 0.393+0.102 
 EEM 49.16+0.48 
 MU 60.95+0.81 
 SPY 270.43-0.06 
Partners & Brokers